MaltSci 麦伴科研

Appearance

Popular Reports / Emerging Frontiers

This report is written by MaltSci based on the latest literature and research findings

How does cell printing advance regenerative medicine? ​

Abstract ​

Regenerative medicine has experienced remarkable advancements, particularly with the advent of cell printing technology, which allows for the precise placement of living cells in three-dimensional (3D) structures to create biomimetic tissues. This review explores the principles and methodologies underlying cell printing, including microextrusion, inkjet, and laser-assisted techniques, each offering unique advantages for tissue engineering applications. The integration of stem cells into bioprinting processes has opened new avenues for creating complex tissue structures tailored to specific clinical needs. Despite the potential of cell printing to address organ shortages and enhance patient outcomes, significant challenges persist, including issues of biocompatibility, cell viability post-printing, and the establishment of functional vascular networks. Furthermore, the complexity of cell-matrix interactions and the optimization of biomaterials remain critical hurdles in translating laboratory successes to clinical realities. This review synthesizes current findings and highlights future perspectives, focusing on innovations in biomaterials and the potential clinical applications of cell printing technology. As research advances, cell printing is poised to play a pivotal role in shaping the future of regenerative therapies, enhancing the development of functional tissues and organs for clinical use.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Principles of Cell Printing Technology
    • 2.1 Overview of Cell Printing Techniques
    • 2.2 Materials Used in Cell Printing
  • 3 Applications in Regenerative Medicine
    • 3.1 Tissue Engineering
    • 3.2 Organ Printing
  • 4 Challenges and Limitations
    • 4.1 Biocompatibility Issues
    • 4.2 Vascularization and Integration
  • 5 Future Perspectives
    • 5.1 Innovations in Biomaterials
    • 5.2 Potential Clinical Applications
  • 6 Conclusion

1 Introduction ​

The field of regenerative medicine has undergone significant transformation over the past few decades, driven by advancements in technologies that allow for the repair and replacement of damaged tissues and organs. Among these innovations, cell printing has emerged as a groundbreaking technique that enables the precise placement of living cells into three-dimensional (3D) structures, thereby facilitating the creation of biomimetic tissues that closely resemble their natural counterparts. This revolutionary approach utilizes various methodologies, including inkjet printing, laser-assisted printing, and microextrusion, to construct complex tissue architectures that replicate the physiological and mechanical properties of native tissues [1][2]. As the global demand for organ transplantation and tissue repair continues to escalate, cell printing presents a promising solution to address the limitations associated with donor organ shortages and the challenges inherent in traditional tissue engineering strategies [3][4].

The significance of cell printing in regenerative medicine cannot be overstated. By harnessing the potential of living cells and biomaterials, researchers are now able to fabricate functional tissues and organs that can be utilized for therapeutic applications. This capability not only holds promise for improving patient outcomes but also represents a paradigm shift in how we approach the treatment of various medical conditions, including chronic wounds, degenerative diseases, and organ failure [5][6]. Furthermore, the integration of stem cells into the bioprinting process has opened new avenues for creating complex tissue structures that can be tailored to meet specific clinical needs [7][8].

Despite the considerable progress made in the field, the application of cell printing technology is not without its challenges. Issues related to biocompatibility, cell viability post-printing, and the ability to establish functional vascular networks within printed tissues remain critical hurdles that must be addressed to fully realize the potential of this technology [3][6]. Moreover, the complexity of cell-matrix interactions and the need for optimized biomaterials further complicate the translation of laboratory successes into clinical realities [1][9].

This review will provide a comprehensive overview of cell printing technology, structured as follows: we will begin with an exploration of the principles underlying cell printing techniques, including an overview of the various methods employed and the materials utilized in the process. Following this, we will discuss the applications of cell printing in regenerative medicine, focusing on tissue engineering and organ printing. We will then examine the challenges and limitations faced by this technology, specifically addressing biocompatibility issues and the need for effective vascularization and integration of printed tissues. Lastly, we will consider future perspectives in the field, highlighting innovations in biomaterials and potential clinical applications that may arise as research continues to advance. By synthesizing current findings and elucidating future directions, this report aims to illuminate the pivotal role that cell printing is poised to play in shaping the future of regenerative therapies and enhancing the development of functional tissues and organs for clinical use.

2 Principles of Cell Printing Technology ​

2.1 Overview of Cell Printing Techniques ​

Cell printing represents a significant advancement in regenerative medicine by enabling the precise deposition of living cells and biomaterials to create three-dimensional (3D) constructs that can mimic the architecture and functionality of natural tissues. This innovative approach leverages the principles of bioprinting, which combines cells with biomaterials to fabricate complex tissue structures for therapeutic applications.

The fundamental principle of cell printing technology is based on the programmed deposition of cells and biomaterials in a layer-by-layer fashion, allowing for the creation of intricate 3D structures that closely resemble the native extracellular matrix. This process not only facilitates the organization of cells in a spatially controlled manner but also enhances cell viability and functionality, which are critical for successful tissue engineering. The ability to control the spatial arrangement of different cell types and biomaterials is essential for directing cellular behavior and promoting tissue regeneration.

There are several cell printing techniques that have emerged, each with unique advantages and limitations. These techniques include:

  1. Microextrusion Bioprinting: This method involves the continuous extrusion of bioink through a nozzle to form filaments. It allows for the deposition of a wide range of biomaterials and cells, making it suitable for creating large-scale tissue constructs. However, the shear stress during extrusion can affect cell viability.

  2. Inkjet Bioprinting: Utilizing thermal or piezoelectric mechanisms, this technique ejects droplets of bioink onto a substrate. It is advantageous for creating high-resolution structures and allows for the use of a variety of bioinks. However, the size of the droplets may limit the types of cells that can be printed effectively.

  3. Laser-Assisted Bioprinting: This technique employs laser energy to transfer cells and biomaterials onto a substrate. It offers high precision and control over the placement of cells, making it suitable for applications requiring fine detail, such as vascular structures.

  4. Spheroid-Based Bioprinting: This newer approach utilizes cell aggregates (spheroids) to create tissues without the need for traditional scaffolding. It has shown promise in enhancing cell-cell interactions and mimicking the natural tissue environment.

The integration of these cell printing technologies with stem cell biology holds immense potential for regenerative medicine. Stem cells can differentiate into various cell types, providing a renewable source for tissue engineering applications. For instance, 3D bioprinting using stem cells has successfully produced models of skin, bone, cartilage, and even more complex structures like organs. This versatility allows for the development of tailored therapies for a range of diseases and conditions, ultimately contributing to improved patient outcomes.

Despite the promising advancements, challenges remain in the field of cell printing. Issues such as post-printing cell damage, proliferation impairment, and the optimization of final cell density deposition must be addressed to enhance the clinical relevance of these technologies. The use of hydrogels as carriers for cell populations can mitigate some of these challenges by providing a supportive environment that promotes cell survival and function [1], [4], [3].

In summary, cell printing technology significantly advances regenerative medicine by providing innovative methods to create functional tissue constructs. The ability to precisely control cell placement and composition through various printing techniques enables the engineering of complex tissues, paving the way for novel therapeutic strategies and enhancing the potential for successful tissue repair and regeneration.

2.2 Materials Used in Cell Printing ​

Cell printing technology represents a significant advancement in regenerative medicine by enabling the precise deposition of living cells to create three-dimensional (3D) constructs that can mimic the architecture and functionality of native tissues. This technology leverages various techniques, such as microextrusion bioprinting, inkjet bioprinting, and laser-assisted bioprinting, to deposit cells along with biomaterials in a controlled manner, thus allowing for the construction of complex tissue structures.

The principles of cell printing technology revolve around the programmed deposition of cells and biomaterials to create scaffolds that support cell growth and tissue formation. By controlling the spatial arrangement of cells, researchers can direct stem cell fate and engineer functional tissues that are capable of integration into the host environment. This method addresses several limitations of traditional tissue engineering, such as the inability to create intricate structures and the challenges associated with controlling cellular positioning and distribution [2].

Materials used in cell printing include various bioinks that are designed to support cell viability and function. These bioinks can be composed of naturally derived polymers, such as alginate, gelatin, and collagen, which provide a biocompatible environment conducive to cell survival and proliferation. The selection of appropriate biomaterials is crucial, as they must exhibit suitable rheological properties for printing while also promoting cell attachment and growth [3]. Hydrogels have emerged as a popular choice due to their tunable properties, allowing for the optimization of cell density and mechanical support, which are critical for post-printing cell health and tissue functionality [1].

Recent advancements in the field highlight the use of stem cells in bioprinting, as they possess the ability to differentiate into various cell types, making them ideal candidates for tissue engineering applications. By utilizing stem cells in conjunction with 3D printing technologies, researchers have been able to create models that represent healthy and diseased tissues, offering new avenues for studying disease mechanisms and developing therapeutic strategies [8]. Moreover, the integration of stem cells into bioprinted constructs has shown promise in producing functional tissues, including skin, bone, and cartilage, thereby advancing the field of regenerative medicine [4].

In conclusion, cell printing technology advances regenerative medicine by providing a versatile platform for the fabrication of complex tissue structures using living cells. The careful selection of materials and the ability to control cellular organization are key components that enhance the efficacy of tissue engineering applications, ultimately contributing to the development of innovative treatments for various medical conditions.

3 Applications in Regenerative Medicine ​

3.1 Tissue Engineering ​

Cell printing represents a significant advancement in regenerative medicine, particularly in the realm of tissue engineering. This innovative technology allows for the precise deposition of living cells, biomaterials, and growth factors in well-defined spatial patterns, enabling the creation of biomimetic tissue structures. Unlike traditional tissue engineering methods, which often struggle to replicate the complex architectures of native tissues, cell printing facilitates the fabrication of three-dimensional (3D) constructs that can closely mimic the biological and mechanical properties of natural tissues [6].

One of the primary applications of cell printing in regenerative medicine is the engineering of tissues and organs. By combining cells with biomaterials in a controlled manner, cell printing can produce scaffolds that support cell attachment, proliferation, and differentiation. This is particularly important for developing functional tissues that can be used for drug testing, disease modeling, and ultimately, transplantation. For instance, stem cells, which possess the ability to differentiate into various cell types, can be effectively incorporated into 3D bioprinted constructs, leading to the regeneration of complex tissues such as bone, cartilage, and cardiac tissue [2].

Furthermore, the integration of vascular networks within these bioprinted constructs is crucial for their functionality and viability post-implantation. Recent advancements in bioprinting technologies have focused on creating vascularized tissues, which are essential for nutrient and oxygen delivery to the cells within the engineered tissues. Strategies such as direct cell-patterning techniques and the use of biomaterials that support vascularization have been explored to enhance the functionality of bioprinted constructs [10].

Cell printing also addresses several challenges faced by traditional tissue engineering approaches. For example, the ability to maintain cell viability during and after the printing process is a significant concern. Advances in bioink formulations, which include hydrogels and other biomaterials, have improved the survival rates of printed cells and their functional capabilities [11]. Moreover, the flexibility of 3D bioprinting allows for the customization of scaffold properties, such as stiffness and porosity, which can be tailored to meet the specific requirements of different tissue types [12].

Despite these advancements, several challenges remain in the field of cell printing and its applications in regenerative medicine. Issues such as the long-term stability of printed constructs, the complexity of cell interactions within the engineered tissues, and the translation of these technologies from the laboratory to clinical settings need to be addressed [1]. Nevertheless, the potential of cell printing to revolutionize tissue engineering is immense, offering new avenues for the development of therapeutic strategies aimed at repairing or replacing damaged tissues and organs [13].

In conclusion, cell printing stands at the forefront of regenerative medicine, providing innovative solutions to the challenges of tissue engineering. Its ability to create complex, functional tissue constructs with precise spatial control over cellular distribution holds great promise for the future of regenerative therapies. As research continues to advance in this field, the integration of cell printing with other technologies may further enhance its applications and effectiveness in clinical settings.

3.2 Organ Printing ​

Cell printing, particularly through the integration of three-dimensional (3D) bioprinting technologies, represents a significant advancement in the field of regenerative medicine, especially in the context of organ printing. This technology enables the fabrication of complex, patient-specific biological structures that closely mimic the architecture and functionality of natural organs. The ability to print living cells along with biomaterials facilitates the creation of viable tissue constructs, which is crucial for addressing the challenges associated with organ shortages and transplantation.

Recent developments in cell printing technologies have demonstrated their high-throughput potential, precise control, and enhanced reproducibility. These advancements allow for the deposition of living cells to generate intricate 3D biological structures that can be utilized for various applications, including organ development, disease modeling, and personalized medicine [14]. The integration of bioinks—composed of living cells and supportive biomaterials—enables the creation of in vitro tissues and organs, thus facilitating investigations into normal tissue morphogenesis and disease progression [14].

The application of inkjet printing in tissue engineering has also shown promise, where the placement of different cell types into soft scaffolds designed via computer-aided templates allows for precise control over cell placement and tissue growth [15]. This technique not only enables the creation of specific tissue types but also addresses the challenge of vascularization within printed constructs, which is essential for the viability of larger tissue structures [15].

Moreover, extrusion-based cell printing (ECP) has garnered significant attention due to its low cost and versatility. This method allows for the precise fabrication of complex structures, which is critical for organ reconstruction [16]. However, challenges remain, such as ensuring functional vasculature and mimicking the biophysical and biochemical characteristics of native tissues [16]. Advances in bioprinting technology, including the development of multi-axis robotic systems, have improved the ability to print vascularized structures, thereby enhancing the functionality of the printed tissues [17].

3D bioprinting using stem cells further enhances the potential for regenerative medicine. By leveraging the unique properties of stem cells, which can differentiate into various tissue types, researchers can create constructs that not only replicate the structural aspects of organs but also their functional characteristics [7]. The successful application of stem cells in bioprinting opens avenues for patient-specific tissue regeneration, which is particularly valuable in personalized medicine [7].

Overall, the advancements in cell printing technology, including the development of various bioprinting techniques and the use of innovative biomaterials, are revolutionizing regenerative medicine. These technologies are poised to significantly impact the future of organ transplantation and tissue engineering, offering solutions to the pressing challenges of organ shortage and the need for effective regenerative therapies [4][18].

4 Challenges and Limitations ​

4.1 Biocompatibility Issues ​

Cell printing has emerged as a transformative technology in regenerative medicine, particularly in the development of tissue engineering constructs that incorporate living cells. The ability to precisely deposit cells, biomaterials, and growth factors in three-dimensional (3D) patterns allows for the creation of biomimetic tissue structures, which can significantly enhance the functionality and integration of engineered tissues in clinical applications. However, despite its potential, cell printing faces several challenges and limitations, particularly regarding biocompatibility issues.

One of the primary challenges in cell printing is the preservation of cell viability during the printing process. Various printing techniques, such as extrusion and inkjet printing, can subject cells to shear stress, mechanical impact, and thermal effects, which may lead to cell death or alter their phenotype [19]. The impact of these factors on cellular activity is significant; therefore, it is crucial to develop bioinks that not only facilitate the printing process but also protect the cells from the harsh conditions associated with bioprinting [20].

Biocompatibility is another critical issue that must be addressed to ensure the success of cell printing in regenerative medicine. The choice of biomaterials used in the printing process can greatly influence the interactions between cells and their microenvironment. For instance, hydrogels have been widely used due to their favorable properties, such as tunable mechanical characteristics and biological compatibility. However, the limitations of certain hydrogels, such as insufficient mechanical strength or degradation rates that do not match tissue regeneration needs, pose significant hurdles [11].

Moreover, the complexity of achieving a biocompatible microenvironment that supports cell survival, proliferation, and differentiation remains a challenge. It is essential to create scaffolds that mimic the natural extracellular matrix (ECM) in terms of biochemical cues and mechanical properties to enhance cell behavior and tissue formation [21]. The successful integration of bioprinted tissues into the host environment also requires a careful balance of the physical, chemical, and biological properties of the bioinks and the printed constructs [9].

Furthermore, the regulatory landscape surrounding cell-based therapies adds another layer of complexity. The use of living cells in bioprinting raises concerns about the long-term effects and potential risks associated with their implantation. Regulatory approval processes for such therapies are often lengthy and stringent, which can impede the translation of cell printing technologies from the laboratory to clinical settings [2].

In summary, while cell printing presents exciting opportunities for advancing regenerative medicine through the creation of complex tissue constructs, significant challenges remain, particularly concerning biocompatibility. Addressing these issues requires ongoing research into the development of advanced bioinks, improved printing techniques, and a deeper understanding of cell-material interactions to ensure the successful application of cell printing technologies in clinical practice.

4.2 Vascularization and Integration ​

Cell printing represents a significant advancement in regenerative medicine, particularly in the context of creating complex tissue structures that require precise cellular arrangement and functionality. One of the primary applications of cell printing is the engineering of vascularized tissues, which is critical for the successful integration and survival of transplanted tissues.

Recent advances in regenerative medicine highlight the potential to manufacture viable and effective tissue engineering constructs comprising living cells for tissue repair and augmentation. Cell printing techniques have demonstrated promising capabilities in cell patterning, allowing for the precise deposition of stem cells that serve as a blueprint for tissue regeneration guidance. However, several challenges remain, particularly regarding post-printing cell damage, proliferation impairment, and issues related to final cell density deposition[1].

Vascularization is a central challenge in tissue engineering, as effective vascular networks are essential for nutrient and oxygen supply to cells within engineered tissues. The absence of functional vasculature can significantly hinder the viability of larger tissue constructs, making the development of strategies to induce vascularization crucial for the success of regenerative therapies. Various approaches, including material-based strategies and direct cell-patterning techniques, have been explored to create designed vascular networks within tissue constructs[10].

Moreover, bioprinting has emerged as a transformative technology that allows for the creation of architecturally complex scaffolds that can support the spatial distribution of stem cells and facilitate vascularization. The programmed deposition of cells, often accompanied by biomaterials, enables the construction of tissues with specific geometries and functions. However, challenges such as maintaining cell viability, pluripotency, and ensuring the integration of these constructs into host tissues persist[2].

The integration of bioprinted tissues into the host environment is also contingent upon the successful development of vascular networks. The incorporation of vascularization strategies into bioprinting processes is seen as essential for enhancing the functionality of engineered tissues. Innovative bioprinting systems that utilize robotic arms and specialized printing methods have been developed to better preserve cell functions and facilitate the creation of complex vascular structures[17].

Despite the advancements in bioprinting and cell printing technologies, significant obstacles remain. Achieving the desired complexity in vascular networks and ensuring the long-term viability of printed constructs are ongoing challenges. The need for further development in both bioprinting techniques and biomaterial formulations is evident to enhance the clinical relevance of these technologies in regenerative medicine[[pmid:34480961],[pmid:34150737]].

In conclusion, while cell printing and associated bioprinting technologies have advanced the field of regenerative medicine significantly, challenges related to vascularization and integration into the host environment continue to pose limitations. Ongoing research is essential to address these hurdles and to realize the full potential of cell printing in developing effective regenerative therapies.

5 Future Perspectives ​

5.1 Innovations in Biomaterials ​

Cell printing has emerged as a transformative technology in regenerative medicine, facilitating the precise fabrication of tissue constructs that can effectively address various medical needs. The advancements in this field are primarily driven by the ability to create three-dimensional (3D) structures that mimic the complexity of natural tissues, which traditional tissue engineering methods often fail to achieve.

Recent studies highlight the potential of cell printing to revolutionize tissue engineering through several key innovations. Firstly, cell printing allows for the accurate deposition of living cells in predefined spatial arrangements, which is crucial for creating functional tissue architectures. This capability not only enhances the structural integrity of the printed tissues but also supports the maintenance of cell viability and functionality post-printing (Cidonio et al., 2019) [1]. The ability to control cellular positioning and distribution is essential for directing stem cell fate and engineering complex tissues, such as vascular networks, which are vital for the survival and integration of implanted tissues (Tricomi et al., 2016) [2].

Moreover, the integration of hydrogels as bioinks in cell printing has addressed several challenges faced in the field. Hydrogels can be tailored to provide an optimal microenvironment for stem cells, enhancing their proliferation and differentiation while reducing post-printing damage (Salehi Moghaddam et al., 2021) [3]. The use of naturally derived bioinks has shown promise in maintaining the biological properties of printed tissues, allowing for the recreation of complex tissue types, including skin, bone, and cartilage (Ong et al., 2018) [7].

The future perspectives of cell printing in regenerative medicine are promising, particularly with the ongoing research aimed at improving bioink formulations and printing techniques. Innovations in bioink composition, such as the incorporation of growth factors and extracellular matrix components, are expected to enhance the functionality and integration of printed tissues (Tasnim et al., 2018) [8]. Furthermore, the development of advanced printing technologies, including scaffold-free methods and the use of stem cell spheroids, is likely to expand the range of applications for cell printing in regenerative medicine (Lee & Dai, 2017) [6].

In summary, cell printing significantly advances regenerative medicine by enabling the creation of complex, functional tissue constructs that can address the challenges of tissue repair and regeneration. The continued innovation in biomaterials and printing technologies will likely enhance the clinical applicability of these techniques, ultimately leading to improved therapeutic outcomes in the treatment of various diseases and injuries.

5.2 Potential Clinical Applications ​

Cell printing has emerged as a transformative technology in the field of regenerative medicine, significantly enhancing the capabilities of tissue engineering and offering innovative solutions for repairing or replacing damaged tissues and organs. The advancements in this area primarily stem from the ability to precisely control the spatial arrangement of cells and biomaterials, which is critical for creating functional tissue constructs that mimic natural tissues.

Recent studies have highlighted the potential of cell printing to manufacture viable and effective three-dimensional (3D) constructs that comprise living cells for tissue repair and augmentation. Techniques such as cell printing enable the precise deposition of stem cells, serving as a blueprint for guiding tissue regeneration. However, challenges remain, including post-printing cell damage, proliferation impairment, and issues related to final cell density deposition. The incorporation of hydrogels into the printing process has been proposed as a solution to these challenges, as they can be tailored to improve cell viability and function [1].

The synergistic combination of 3D printing and cellular therapies has garnered significant attention, as it is recognized as a promising approach in regenerative medicine. This integration is expected to play a crucial role in treating various diseases and conditions in the future, enhancing tissue repair and organ replacement strategies [4]. The development of advanced bioinks, which are essential for the successful implementation of 3D bioprinting, allows for the reliable recreation of tissues and organs with clinically relevant geometries and sizes [3].

Future perspectives on cell printing in regenerative medicine include addressing the challenges of bioprinting technologies and the need for improved biomaterials that can support cell viability and functionality. Research is focusing on developing new bioinks that facilitate the printing of complex tissue architectures while maintaining the biological functions of the cells and the extracellular matrix [6]. Moreover, the potential for creating vascularized tissues through bioprinting presents an exciting avenue for future research, as vascularization is critical for the survival and integration of transplanted tissues [22].

The clinical applications of cell printing are vast, ranging from skin and bone to more complex structures such as cardiac and neural tissues. The ability to produce patient-specific tissues using stem cells not only holds promise for transplantation but also provides a platform for drug testing and disease modeling [2]. Furthermore, the advent of technologies that allow for scaffold-free printing and the use of bioinks derived from natural materials enhances the biocompatibility and functionality of the printed constructs [23].

In conclusion, cell printing stands at the forefront of regenerative medicine, with the potential to revolutionize how tissues are engineered and repaired. As research progresses, the focus will likely shift towards overcoming current limitations, enhancing the efficacy of bioprinted tissues, and translating these innovations into clinical practice. The integration of advanced materials and bioprinting techniques will be crucial in realizing the full potential of regenerative therapies in addressing complex medical challenges.

6 Conclusion ​

Cell printing has emerged as a transformative technology in regenerative medicine, offering innovative solutions for the creation of functional tissue constructs. The major findings indicate that cell printing techniques, such as microextrusion, inkjet, and laser-assisted bioprinting, enable precise control over the spatial arrangement of cells and biomaterials, which is crucial for mimicking the complex architecture of natural tissues. While the advancements in this field hold great promise for applications in tissue engineering and organ printing, significant challenges remain, particularly regarding biocompatibility, cell viability post-printing, and the establishment of functional vascular networks within printed constructs. The evaluation of current research reveals a need for ongoing exploration into advanced biomaterials and printing techniques to address these challenges. Future research directions should focus on the development of innovative bioinks that enhance cell survival and functionality, as well as the integration of vascularization strategies to improve the viability of larger tissue constructs. As the field progresses, the synergy between cell printing and stem cell technology is expected to yield patient-specific tissues that can be utilized for transplantation, drug testing, and disease modeling, ultimately revolutionizing regenerative therapies and improving patient outcomes.

References ​

  • [1] G Cidonio;M Glinka;J I Dawson;R O C Oreffo. The cell in the ink: Improving biofabrication by printing stem cells for skeletal regenerative medicine.. Biomaterials(IF=12.9). 2019. PMID:31022557. DOI: 10.1016/j.biomaterials.2019.04.009.
  • [2] Brad J Tricomi;Andrew D Dias;David T Corr. Stem cell bioprinting for applications in regenerative medicine.. Annals of the New York Academy of Sciences(IF=4.8). 2016. PMID:27870077. DOI: 10.1111/nyas.13266.
  • [3] Abolfazl Salehi Moghaddam;Hossein Ali Khonakdar;Mohammad Arjmand;Seyed Hassan Jafari;Zohreh Bagher;Zahra Salehi Moghaddam;Mohammadreza Chimerad;Mahsa Mollapour Sisakht;Shahrokh Shojaei. Review of Bioprinting in Regenerative Medicine: Naturally Derived Bioinks and Stem Cells.. ACS applied bio materials(IF=4.7). 2021. PMID:35006822. DOI: 10.1021/acsabm.1c00219.
  • [4] Ana Catarina Sousa;Rui Alvites;Bruna Lopes;Patrícia Sousa;Alícia Moreira;André Coelho;José Domingos Santos;Luís Atayde;Nuno Alves;Ana Colette Maurício. Three-Dimensional Printing/Bioprinting and Cellular Therapies for Regenerative Medicine: Current Advances.. Journal of functional biomaterials(IF=5.2). 2025. PMID:39852584. DOI: 10.3390/jfb16010028.
  • [5] Kevin Las Heras;Manoli Igartua;Edorta Santos-Vizcaino;Rosa Maria Hernandez. Cell-based dressings: A journey through chronic wound management.. Biomaterials advances(IF=6.0). 2022. PMID:35929212. DOI: 10.1016/j.bioadv.2022.212738.
  • [6] Vivian K Lee;Guohao Dai. Printing of Three-Dimensional Tissue Analogs for Regenerative Medicine.. Annals of biomedical engineering(IF=5.4). 2017. PMID:27066784. DOI: 10.1007/s10439-016-1613-7.
  • [7] Chin Siang Ong;Pooja Yesantharao;Chen Yu Huang;Gunnar Mattson;Joseph Boktor;Takuma Fukunishi;Huaitao Zhang;Narutoshi Hibino. 3D bioprinting using stem cells.. Pediatric research(IF=3.1). 2018. PMID:28985202. DOI: 10.1038/pr.2017.252.
  • [8] Nishat Tasnim;Laura De la Vega;Shweta Anil Kumar;Laila Abelseth;Matthew Alonzo;Meitham Amereh;Binata Joddar;Stephanie M Willerth. 3D Bioprinting Stem Cell Derived Tissues.. Cellular and molecular bioengineering(IF=5.0). 2018. PMID:31719887. DOI: 10.1007/s12195-018-0530-2.
  • [9] Stuart Kyle;Zita M Jessop;Ayesha Al-Sabah;Iain S Whitaker. 'Printability' of Candidate Biomaterials for Extrusion Based 3D Printing: State-of-the-Art.. Advanced healthcare materials(IF=9.6). 2017. PMID:28558161. DOI: 10.1002/adhm.201700264.
  • [10] Afonso Malheiro;Paul Wieringa;Carlos Mota;Matthew Baker;Lorenzo Moroni. Patterning Vasculature: The Role of Biofabrication to Achieve an Integrated Multicellular Ecosystem.. ACS biomaterials science & engineering(IF=5.5). 2016. PMID:33440469. DOI: 10.1021/acsbiomaterials.6b00269.
  • [11] Matangi Parimala Chelvi Ratnamani;Xinping Zhang;Hongjun Wang. A Comprehensive Assessment on the Pivotal Role of Hydrogels in Scaffold-Based Bioprinting.. Gels (Basel, Switzerland)(IF=5.3). 2022. PMID:35448140. DOI: 10.3390/gels8040239.
  • [12] Ahmed Fatimi;Oseweuba Valentine Okoro;Daria Podstawczyk;Julia Siminska-Stanny;Amin Shavandi. Natural Hydrogel-Based Bio-Inks for 3D Bioprinting in Tissue Engineering: A Review.. Gels (Basel, Switzerland)(IF=5.3). 2022. PMID:35323292. DOI: 10.3390/gels8030179.
  • [13] Jianmin Xue;Chen Qin;Chengtie Wu. 3D printing of cell-delivery scaffolds for tissue regeneration.. Regenerative biomaterials(IF=8.1). 2023. PMID:37081861. DOI: 10.1093/rb/rbad032.
  • [14] Yu-Han Ho;Yuanhong Liao;Lingni Liao;Tianjiao Mao;Yimin Guan;Ren Xu. Advances of Cell Printing Technology in Organoid Engineering.. Tissue engineering. Part B, Reviews(IF=4.6). 2025. PMID:40501290. DOI: 10.1089/ten.teb.2025.0048.
  • [15] Thomas Boland;Tao Xu;Brook Damon;Xiaofeng Cui. Application of inkjet printing to tissue engineering.. Biotechnology journal(IF=3.1). 2006. PMID:16941443. DOI: 10.1002/biot.200600081.
  • [16] Ge Gao;Byoung Soo Kim;Jinah Jang;Dong-Woo Cho. Recent Strategies in Extrusion-Based Three-Dimensional Cell Printing toward Organ Biofabrication.. ACS biomaterials science & engineering(IF=5.5). 2019. PMID:33405637. DOI: 10.1021/acsbiomaterials.8b00691.
  • [17] Zeyu Zhang;Chenming Wu;Chengkai Dai;Qingqing Shi;Guoxin Fang;Dongfang Xie;Xiangjie Zhao;Yong-Jin Liu;Charlie C L Wang;Xiu-Jie Wang. A multi-axis robot-based bioprinting system supporting natural cell function preservation and cardiac tissue fabrication.. Bioactive materials(IF=20.3). 2022. PMID:35387155. DOI: 10.1016/j.bioactmat.2022.02.009.
  • [18] Victor M Arias-Peregrino;Aldo Y Tenorio-Barajas;Claudia O Mendoza-Barrera;Jesús Román-Doval;Esteban F Lavariega-Sumano;Sandra P Torres-Arellanes;Ramón Román-Doval. 3D Printing for Tissue Engineering: Printing Techniques, Biomaterials, Challenges, and the Emerging Role of 4D Bioprinting.. Bioengineering (Basel, Switzerland)(IF=3.7). 2025. PMID:41007181. DOI: 10.3390/bioengineering12090936.
  • [19] Jaideep Adhikari;Avinava Roy;Anindya Das;Manojit Ghosh;Sabu Thomas;Arijit Sinha;Jinku Kim;Prosenjit Saha. Effects of Processing Parameters of 3D Bioprinting on the Cellular Activity of Bioinks.. Macromolecular bioscience(IF=4.1). 2021. PMID:33017096. DOI: 10.1002/mabi.202000179.
  • [20] Amirmasoud Samadi;Ali Moammeri;Mehrab Pourmadadi;Parisa Abbasi;Zeinab Hosseinpour;Arian Farokh;Amin Shamsabadipour;Maryam Heydari;M Rezaa Mohammadi. Cell Encapsulation and 3D Bioprinting for Therapeutic Cell Transplantation.. ACS biomaterials science & engineering(IF=5.5). 2023. PMID:36877212. DOI: 10.1021/acsbiomaterials.2c01183.
  • [21] Yu Shrike Zhang;Kan Yue;Julio Aleman;Kamyar Mollazadeh Moghaddam;Syeda Mahwish Bakht;Jingzhou Yang;Weitao Jia;Valeria Dell'Erba;Pribpandao Assawes;Su Ryon Shin;Mehmet Remzi Dokmeci;Rahmi Oklu;Ali Khademhosseini. 3D Bioprinting for Tissue and Organ Fabrication.. Annals of biomedical engineering(IF=5.4). 2017. PMID:27126775. DOI: 10.1007/s10439-016-1612-8.
  • [22] Gregor Skeldon;Baltasar Lucendo-Villarin;Wenmiao Shu. Three-dimensional bioprinting of stem-cell derived tissues for human regenerative medicine.. Philosophical transactions of the Royal Society of London. Series B, Biological sciences(IF=4.7). 2018. PMID:29786559. DOI: 10.1098/rstb.2017.0224.
  • [23] Manal Hussein Taghdi;Barathan Muttiah;Alvin Man Lung Chan;Mh Busra Fauzi;Jia Xian Law;Yogeswaran Lokanathan. Exploring Synergistic Effects of Bioprinted Extracellular Vesicles for Skin Regeneration.. Biomedicines(IF=3.9). 2024. PMID:39062178. DOI: 10.3390/biomedicines12071605.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

Cell Printing · Regenerative Medicine · Biomaterials

© 2025 MaltSci